Table 3.
Associated of clinical and laboratory factors with LD in SLE. p values reflect two-tailed χ2 test. p values < 0.05 are in italics.
| Normal (N) | iLD | LD | pN vs. iLD | pN vs. iLD + LD | piLD vs. LD | pN vs. LD | |
|---|---|---|---|---|---|---|---|
| SMA (+) | 10 (13.0%) | 11 (26.8%) | 13 (29.5%) | 0.06 | 0.02 | 0.78 | 0.03 |
| SMA (−) | 67 (87.0%) | 30 (73.2%) | 31 (70.5%) | ||||
| AMA (+) | 4 (5.1%) | 3 (7.3%) | 1 (2.3%) | 0.62 | 0.92 | 0.28 | 0.47 |
| AMA (−) | 75 (94.9%) | 38 (92.7%) | 42 (97.7%) | ||||
| Proteinuria (+) | 20 (9.2%) | 16 (12.8%) | 18 (20.5%) | 0.30 | 0.03 | 0.13 | 0.007 |
| Proteinuria (−) | 197 (90.8%) | 109 (87.2%) | 70 (79.5%) | ||||
| Anti-DNA (+) | 20 (11.9%) | 13 (14.9%) | 17 (27.4%) | 0.49 | 0.048 | 0.06 | 0.005 |
| Anti-DNA (−) | 148 (88.1%) | 74 (85.1%) | 45 (72.6%) | ||||
| Hypocomplementemia | 43 (25.9%) | 27 (28.7%) | 28 (41.8%) | 0.62 | 0.10 | 0.08 | 0.02 |
| Normal Complement | 123 (74.1%) | 67 (71.3%) | 39 (58.2%) | ||||
| WBC <4000 K/ul | 6 (2.8%) | 2 (1.6%) | 8 (8.9%) | 0.49 | 0.30 | 0.01 | 0.02 |
| WBC > 4000/ul | 211 (97.2%) | 124 (99.2%) | 82 (91.1%) | ||||
| Platelet <100,000/ul | 6 (2.8%) | 7 (5.6%) | 12 (13.3%) | 0.17 | 0.007 | 0.047 | 0.0003 |
| Platelet >100,000/ul | 211 (97.2%) | 119 (94.4%) | 78 (86.7%) | ||||
| APS (+) | 28 (14.0%) | 20 (17.0%) | 25 (30.0%) | 0.52 | 0.038 | 0.039 | 0.0025 |
| APS (−) | 171 (86.0%) | 98 (83.0%) | 58 (70.0%) |